Chronic kidney disease trials in Netherlands
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Amersfoort, Amsterdam, Dordrecht, Groningen, Hilversum, Leiden, Maastricht, Nieuwegein, Zwolle
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Almere, Amersfoort, Amsterdam, Apeldoorn, Arnhem, Dirksland, Doetinchem, Dordrecht, Eindhoven, Gouda, Groningen, Heerenveen, Leeuwarden, Leiderdorp, Nijmegen, Roosendaal, Schiedam, 'S-Hertogenbosch, Utrecht, Veldhoven, Venlo
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseEnrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Nijmegen
- Age
- 0 Minutes to 2 weeks
- People
- 8,000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - No phaseTaking peopleStreamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- Where
- Heerlen, Rotterdam
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT07115953 - Phase 3Taking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Groningen
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - Phase 3Taking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Groningen, Utrecht
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Apeldoorn, Eindhoven, Rotterdam
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleThe Microcirculation, Dialysis Modality and Sequestered Salt
- Where
- Amstelveen, Amsterdam
- Age
- 18 years and over
- People
- 23
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06327750 - Phase 1Not yet taking people in NetherlandsTargeting fibrotic tissue with a radioactive-labelled Fibrobody, visible using a full-body PET/CT scan (FibroVision)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 57
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-521143-20-00 · EU 2025-521143-20-00 - No phaseTaking peopleHypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 15
- Run by
- Vivalyx GmbH
See details and how to joinNCT07792317 - Phase 3Taking peopleSACK
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 1,281 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2022-501600-10-00 · EU 2022-501600-10-00 - Phase 2Taking peopleComparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
- Where
- Groningen
- Age
- 18 years and over
- People
- 100
- Run by
- University Medical Center Groningen
See details and how to joinNCT07304817 · EU 2025-523743-35-00 - Phase 2Taking peopleAlbuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)
- Where
- Almelo, Arnhem, Dordrecht, Groningen, Leeuwarden
- Age
- 18 years and over
- People
- 95 worldwide
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2025-525068-13-00 · EU 2025-525068-13-00 - No phaseNot yet taking people in NetherlandsSweet & Sour: Dietary Acid Load in Type 2 Diabetes and Kidney Disease Across Sex and Ethnic Groups
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 80
- Run by
- Erasmus Medical Center
See details and how to joinNCT07587918 - Phase 4Not yet taking people in NetherlandsCANagliflozin In DIALysis Patients
- Where
- Groningen
- Age
- 18 years and over
- People
- 10
- Run by
- University Medical Center Groningen
See details and how to joinNCT07527390 · EU 2025-522742-46-00 - Phase 4Taking peoplemethod VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate
- Where
- Groningen
- Age
- 18 years and over
- People
- 200
- Run by
- Universitair Medisch Centrum Groningen
See details and how to joinNCT06259422 · EU 2023-509156-34-02 - Phase 4Taking peoplePotassium Correction for RAAS Optimization in Chronic Kidney Disease
- Where
- Groningen
- Age
- 18 years and over
- People
- 44
- Run by
- University Medical Center Groningen
See details and how to joinNCT06256991 - Phase 4Taking peoplePROMISE
- Where
- Amsterdam, Groningen, Leeuwarden, Zwolle
- Age
- 18 years and over
- People
- 44
- Run by
- University Medical Center Groningen
See details and how to join2023-505626-34-01 · EU 2023-505626-34-01 - No phaseNot yet taking people in NetherlandsPhysical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
- Where
- Groningen
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Biogem s.c.ar.l.
See details and how to joinNCT07160959 - No phaseTaking peopleUrinary Tubular Biomarkers for Chronic Kidney Disease
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 556
- Run by
- Erasmus Medical Center
See details and how to joinNCT06732349 - No phaseTaking peopleDiuretic Testing in Chronic Kidney Disease
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 86
- Run by
- Erasmus Medical Center
See details and how to joinNCT06841692 - No phaseTaking peopleFirst-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
- Where
- Utrecht
- Age
- 18 years and over
- People
- 12 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT06314503 - No phaseTaking peopleThe Role of Skin Sodium Accumulation in Chronic Kidney Disease
- Where
- Amsterdam-Zuidoost
- Age
- 18 years and over
- People
- 60
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT07020104 - No phaseEnrolling by invitationCheck@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease
- Where
- Amsterdam
- Age
- 50 years to 75 years
- People
- 320,000
- Run by
- Prof. Dr. Folkert W. Asselbergs
See details and how to joinNCT06330480 - No phaseTaking peopleStudy to Examine the Effect of the Diuretic Furosemide on the Plasma Levels of Toxins and the Removal of Toxins from the Blood in Patients with Chronic Kidney Disease
- Where
- Utrecht
- Age
- 18 years and over
- People
- 34
- Run by
- UMC Utrecht
See details and how to joinNCT06750575